WuXi AppTec Co., Ltd. (HKG:2359)

Market Cap	180.81B
Revenue (ttm)	42.45B
Net Income (ttm)	11.99B
Shares Out	n/a
EPS (ttm)	3.48
PE Ratio	15.08
Forward PE	n/a
Dividend	1.09 (1.74%)
Ex-Dividend Date	May 15, 2025

Volume	3,651,687
Average Volume	8,895,740
Open	61.50
Previous Close	61.50
Day's Range	60.40 - 61.50
52-Week Range	27.50 - 76.00
Beta	0.87
RSI	53.64
Earnings Date	Apr 28, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2359

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY